| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/06/2006 | CN1827160A Chinese medicinal composition for treating enteritis |
| 09/06/2006 | CN1827149A Health-preserving liquor and method for preparing the same |
| 09/06/2006 | CN1827146A Health-caring food for preventing and treating acute and chronic laryngopharyngitis and method for preparing the same |
| 09/06/2006 | CN1827139A Liver beneficial pharmaceutical composition and method for preparing the same |
| 09/06/2006 | CN1827132A Medicine for treating cholestasis and hepatic fibrosis and method for preparing the same |
| 09/06/2006 | CN1827124A Dripping pills of herba lamiophlomis rotatae and method for preparing the same |
| 09/06/2006 | CN1827119A Chinese medicinal compound preparation capable of relieving exterior syndrome, digesting food and eliminating sputum and method for preparing the same |
| 09/06/2006 | CN1827115A Film-coated tablet of glycyrrhizinic acid monopotassiium salt and method for preparing the same |
| 09/06/2006 | CN1827093A Taurine injection and method for preparing the same |
| 09/06/2006 | CN1827088A Preparation method of Chinese medicinal injection for treating hepatitis and injection prepared thereby |
| 09/06/2006 | CN1826982A Edible and portable nutritious health-caring mutton soup |
| 09/06/2006 | CN1826958A Health-caring vermicelli with cogongras rhizome |
| 09/06/2006 | CN1826954A Health-caring vermicelli with fresh-water turtle shell |
| 09/06/2006 | CN1273482C Hepatitis C virus tunic protein E2 gene capable of being total length expressed in E. coli, its coding protein and use |
| 09/06/2006 | CN1273464C Optically pure R-(+)- Omeprazole prepn process |
| 09/06/2006 | CN1273463C (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for production thereof and pharmaceutical compositions containing the same |
| 09/06/2006 | CN1273454C New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 09/06/2006 | CN1273450C 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6ligands |
| 09/06/2006 | CN1273196C Target directional confluent DNA vaccine for preventing caries and preparation method thereof |
| 09/06/2006 | CN1273193C Method for preparing biologics of yolk antibody for resisting Helicobacter Pylori |
| 09/06/2006 | CN1273191C Method and composition for altering a B cell mediated pathology |
| 09/06/2006 | CN1273182C Medicine for treating gastric disease and its preparation method |
| 09/06/2006 | CN1273174C Gastrosis-treating medicine |
| 09/06/2006 | CN1273172C Medicine for treating chronic colonitis |
| 09/06/2006 | CN1273170C Capsule of Chinese traditional medicine for treating diseases caused by insufficiency of kidney-yang and deficiency of blood |
| 09/06/2006 | CN1273166C Health-care product with functions of prolonging life and nourishing face |
| 09/06/2006 | CN1273157C Traditional Chinese medicine for curing functional indigestion and its preparing process |
| 09/06/2006 | CN1273140C Cathartic composition |
| 09/06/2006 | CN1273134C Soft capsule of fibrauretine and preparation method thereof |
| 09/06/2006 | CN1273110C System treatment of a mucosal surface |
| 09/06/2006 | CN1273049C Health-care food and preparation method thereof |
| 09/06/2006 | CN1273030C Protein material for slow digestion and its use |
| 09/05/2006 | US7102013 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative |
| 09/05/2006 | US7102009 For treating cancer and angiogenesis-related disorders |
| 09/05/2006 | US7102007 Dihydroindole and tetrahydroquinoline derivatives |
| 09/05/2006 | US7101977 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor |
| 09/05/2006 | US7101974 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis |
| 09/05/2006 | US7101960 Process for removing bile salts from a patient and alkylated compositions therefor |
| 09/05/2006 | US7101910 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 09/05/2006 | US7101907 Topical administration of statins for treatment of bone disorders |
| 09/05/2006 | US7101899 N-[4-[2-Ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide; adenosine A3 receptor antagonistic activity |
| 09/05/2006 | US7101896 Pharmaceutical compositions and methods for use |
| 09/05/2006 | US7101882 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 09/05/2006 | US7101868 A 2-(((4-fluorophenyl)methyl)amino)-3-pyridinecarboxamide derivatives for treating cancer, angiogenesis, tumor |
| 09/05/2006 | US7101864 N-(2-acetamidoethyl)phosphonoformamide; inhibiting effect on zinc-containing proteinases, inhibiting cancer cells |
| 09/05/2006 | US7101863 For skin, muscle, ocular or gastric mucosal healing |
| 09/05/2006 | US7101861 For therapy and prophylaxis of host infected with flavivirus or pestivirus |
| 09/05/2006 | US7101853 Provided amylin agonist is not calcitonin; also amylin used in combination with an nonsteroidal antiinflammatory agent to relieve pain, thereby achieving a synergistic effect |
| 09/05/2006 | US7101851 IgE receptor antagonists |
| 09/05/2006 | US7101843 Amino acid sequence of His-Val-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Glu-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Ile-Lys-Gly-Arg-Gly-OH; obesity, stroke, myocardial infarction, irritable bowel syndrome, non-insulin dependent diabetes |
| 09/05/2006 | US7101562 Conjugate vaccines for the prevention of dental caries |
| 09/05/2006 | US7101550 Agents for modulating PD-1, B7-4, and the interaction between B7-4 and PD-1 in order to modulate a costimulatory or an inhibitory signal in a immune cell resulting in modulation of the immune response |
| 09/05/2006 | CA2393640C Pyrrolo[2,3-d]pyrimidine compounds |
| 08/31/2006 | WO2006091903A1 Method of treatment of diarrhea-predominant irritable bowel syndrome in a subject |
| 08/31/2006 | WO2006090932A1 Surrogate marker for sulfonamide compound |
| 08/31/2006 | WO2006090921A1 Inhibitory effect of sulfonamide compound on lymphocyte activation |
| 08/31/2006 | WO2006090640A1 Tablet composition containing amino acid and process for producing tablet |
| 08/31/2006 | WO2006090616A1 Fat cell differentiation regulator |
| 08/31/2006 | WO2006090279A1 Oxyindole derivatives as 5ht4 receptor agonists |
| 08/31/2006 | WO2006090206A1 Improved extracts of psidium guajava l., methods for its obtaining and use for the treatment of gastrointestinal disorders |
| 08/31/2006 | WO2006089803A1 Method and composition to inhibit infections with helicobacter pylori by intake of procyanidins from type b and c |
| 08/31/2006 | WO2006089549A1 Ykl-40 monoclonal antibodies |
| 08/31/2006 | WO2006066924A3 Azole derivatives with antimuscarinic activity |
| 08/31/2006 | WO2006038107A3 Method for inhibiting fibrogenesis by an rhdecorin-fc fusion protein |
| 08/31/2006 | US20060194969 4-Substituted benzimidazoles and their uses as inhibitors of gastric secretion |
| 08/31/2006 | US20060194968 Cyclic benizimidazoles |
| 08/31/2006 | US20060194872 Diamine derivative, production process therefor and antioxidant |
| 08/31/2006 | US20060194864 Indole derivatives |
| 08/31/2006 | US20060194863 e.g. [(4-Morpholinophenylamino)-methylene]-1,3-dihydro-indol-2-one;tyrosine kinase signal transduction modulators; antiproliferative agents; vision defects, atherosclerosis, restenosis, metabolic disorders, autoimmune diseases |
| 08/31/2006 | US20060194850 methyl 3-(4-{4-[1-(2-chlorophenyl)ethoxycarbonylamino]-3-isoxazolyl}-benzylsulfanyl)propionate; compounds inhibit the physiological activity of lysophosphatidic acid (LPA); treatment of fibrosis of organs (liver, kidney, lung, and the like), hepatic disease |
| 08/31/2006 | US20060194848 Substituted amine derivatives and methods of use |
| 08/31/2006 | US20060194841 Benzylamine derivative |
| 08/31/2006 | US20060194832 Enantiomer (-) of tenatoprazole and the therapeutic use thereof |
| 08/31/2006 | US20060194818 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194793 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194792 1-Cyclic carbonyl-4-(4-quinoline-)-1,4-diazepine or 1-cyclic carbonyl-4-[4-(1H-quinolin-2-{thio}one)-1,4-diazepinone derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 08/31/2006 | US20060194787 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 08/31/2006 | US20060194782 Pharmacologically active imidazo[4,5-c] pyridines |
| 08/31/2006 | US20060194745 Compounds and methods for inhibiting selectin-mediated function |
| 08/31/2006 | US20060193929 Method for treating or preventing symptoms associated with menopause |
| 08/31/2006 | US20060193874 Vaccines for proliferative ileitis and methods of making and using the same |
| 08/31/2006 | US20060193871 transmission and, or amplification of signal; oral or enteric administering, dissolving, absorption; peptide yy; obesity therapy |
| 08/31/2006 | US20060193790 Promoting whole body health |
| 08/31/2006 | CA2599439A1 Ykl-40 monoclonal antibody |
| 08/31/2006 | CA2599206A1 Method of treatment of diarrhea-predominant irritable bowel syndrome in a subject |
| 08/31/2006 | CA2598961A1 Nutritional composition with probiotics |
| 08/30/2006 | EP1695983A2 Glucagon-like peptide-1 analogs |
| 08/30/2006 | EP1695982A1 Glycosylation-deficient hepatocyte growth factor |
| 08/30/2006 | EP1695974A1 1,8-Naphthyridines as CRF antagonists |
| 08/30/2006 | EP1695713A1 Enteropathy ameliorating composition |
| 08/30/2006 | EP1695698A1 Anti-angiogene compositions and methods of use |
| 08/30/2006 | EP1695697A1 Anti-angiogenic compositions and methods of use |
| 08/30/2006 | EP1694656A1 Benzoxazine derivatives and uses thereof |
| 08/30/2006 | EP1694345A1 Compositions and methods for the treatment of lysosomal storage disorders |
| 08/30/2006 | EP1694273A2 Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
| 08/30/2006 | EP1513837B1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 08/30/2006 | EP1482811B1 Process for the preparation of foods comprising a probiotic delivery system |
| 08/30/2006 | EP1445262B1 Peptide derivative, pharmaceutically acceptable salt thereof, process for producing the same, and use thereof |
| 08/30/2006 | EP1425280B1 Hetero-bicyclic crf antagonists |
| 08/30/2006 | EP1414810B1 1,4-disubstituted benzo-fused cycloalkyl urea compounds |